by John Moore III | June 19, 2020
Watch the recording new;ly available from the first of our COVID Lessons Learned webinar series. Enter your contact info below to begin watching and to receive the slides (check for an email from john3 [at] chilmarkresearch.com if you don't see anything within a few minutes). Panelists: Dr. Lu de Souza,
by Chilmark Team | December 15, 2017
Our favorite post of the year is this one. As analysts, we come together with our propeller hats on to collectively look ahead at the key trends in the year to come in the healthcare sector. While there are any number of predictions one might make for this dynamic market,
by Chilmark Team | December 11, 2017
In keeping with a Chilmark Research tradition, once again we step into our “way-back machine” to review our 2017 predictions for the healthcare sector - of course with a health IT flavor. Our score is far from perfect, but we did quite well with our 2017 predictions: 7 Hits, 2
by Chilmark Team | October 19, 2017
What a whirlwind it has been – three major conferences for Chilmark Research analysts in three consecutive weeks. Sure, the Epic UGM and Cerner CHC are industry leading events, but our own humble, inaugural event, Convergence, was influential in its own right. Attendees, speakers, and panelists from across the healthcare
by Ken Kleinberg | August 11, 2017
About a year ago, I met John Moore – we were listening to a prominent health IT vendor describe their current product and service portfolio, customer references, go-to-market strategy, etc. John and I glanced at each other more than once, eyebrows raised at the same time. We chatted a bit
by John Moore | March 28, 2017
Much consternation has been expressed over the years regarding massive enterprise software roll-outs. There are numerous examples in virtually any industry sector one cares to look at. Years ago, when I was working as an analyst in the manufacturing vertical, the stories were legendary of ERP deployments gone awry and
by Jennifer Rogers | March 14, 2017
Healthcare is a study in extremes. On the precise end of the continuum, we have the surgical precision of the neurosurgeon’s scalpel and the micro-precision of genomic studies. On the not-even-close-to-precise opposite end of the continuum, we have the very elements that frame our industry’s care models and Population Health
by Jennifer Rogers | March 01, 2017
Our industry was in state of unrest going into HIMSS17. Some would call it panic. This year’s HIMSS was as much a REALLY large group therapy session as it was a trade show. Seemed as if everyone was reassuring each other again and again, “Value-based care (VBC) has left the
